This announcement is a separate document:
莱美药业:北京市中伦律师事务所关于重庆莱美药业股份有限公司2023年第三次临时股东大会的法律意见书
Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the Third Extraordinary General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd. in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.